menu
    • menu

    Company profile for POP Biotechnologies

    NEW Drugs in Dev: 2
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    POP Biotechnologies, Inc is Buffalo NY biotechnology company focused on the development of innovative biomedical solutions harnessing next-generation nanotechnologies designed to treat cancer and other life-threatening diseases. The company specializes in the development and commercialization of targeted, nanoparticle-based, drug delivery systems and formulations using novel platform technology that releases payload drugs upon...
    POP Biotechnologies, Inc is Buffalo NY biotechnology company focused on the development of innovative biomedical solutions harnessing next-generation nanotechnologies designed to treat cancer and other life-threatening diseases. The company specializes in the development and commercialization of targeted, nanoparticle-based, drug delivery systems and formulations using novel platform technology that releases payload drugs upon near-infrared light activation, enabling healthcare providers to meet patient needs in oncology and infectious diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    POP BiotechnologiesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Baird Research Park, Suite 221 1576 Sweet Home Road Buffalo, NY 14228-2710
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://pop.bio/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/popbio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pop Bio Secures $2.46M NIH Grant For Alzheimer's Immunotherapy
    Pop Bio Secures $2.46M NIH Grant For Alzheimer's Immunotherapy

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/01/3159937/0/en/POP-Biotechnologies-Awarded-2-46M-NIH-Grant-for-Alzheimer-s-Immunotherapy.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share
    POP Bio, CEPI Collaborate to Speed up Responses to Disease X
    POP Bio, CEPI Collaborate to Speed up Responses to Disease X

    25 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/25/3121975/0/en/POP-BIO-and-CEPI-announce-collaboration-for-faster-responses-to-Disease-X.html

    GLOBENEWSWIRE
    25 Jul 2025
    Share Share
    Nanoparticle Vaccine Protects 100% Against H5N1 in Trials
    Nanoparticle Vaccine Protects 100% Against H5N1 in Trials

    21 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/r-e-p-e-a-t----magnet-like-nanoparticle-vaccine-achieves-100-protection-against-h5n1-in-preclinical-trials-302433713.html

    PR NEWSWIRE
    21 Apr 2025
    Share Share
    Nanoparticle Vaccine Protects 100% Against H5N1 in Preclinical Trial
    Nanoparticle Vaccine Protects 100% Against H5N1 in Preclinical Trial

    17 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/magnet-like-nanoparticle-vaccine-achieves-100-protection-against-h5n1-in-preclinical-trials-302431826.html

    PR NEWSWIRE
    17 Apr 2025
    Share Share
    POP Bio & EuBiologics' EuCorVac-19 COVID-19 Vaccine Hits Target in Phase 3 Trial
    POP Bio & EuBiologics' EuCorVac-19 COVID-19 Vaccine Hits Target in Phase 3 Trial

    14 Jul 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=767976&lang=en

    ACCESSWIRE
    14 Jul 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search